Compugen | CGEN - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Arca Biopharma USD -36.43M 2M 2026-03
aTyr Pharma USD -104K 24K 2026-06
Bio Path USD -297K 191K 2026-03
Brainstorm Cell Therapeutics USD -2.05M 198K 2026-03
Cara Therapeutics USD -7.05M 1.11M 2026-03
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -8.84M 180K 2026-06
Immunic USD -23.33M 2.67M 2025-12
Minerva Neurosciences USD -21.85M 17.48M 2024-12
RedHill Biopharma USD -4.22M 1.8M 2024-06
TherapeuticsMD USD -1.18M 40K 2024-06